MedTrace Logo

A Trial of Magnesium Dependent Tinnitus

NCT01273883 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2015-04-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to examine any potential benefit in lessening the severity of tinnitus (ringing or booming sensation in one or both ears) in subjects supplemented with magnesium (532 mg daily).

Conditions

  • Tinnitus

Interventions

DIETARY_SUPPLEMENT

Magnesium

Magnesium 532 mg a day

OTHER

Placebo

matching form/dosage

Sponsors & Collaborators

Principal Investigators

  • Michael Cevette, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01273883 on ClinicalTrials.gov